1-20 of 24
Chiung-Yu Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short survival with BCMA and GPRC5D dual antigen exposed relapsed myeloma- an international myeloma working group immunotherapy database analysis

Free
Murali Janakiram, Thomas Martin, Mrugakshi Dave, Chiung-Yu Huang, Sireesha Asoori, Myo Htut, Andre De Menezes Silva Corraes, Prashant Kapoor, Chris Lau Wai Pan, Carlyn Tan, Saad Usmani, Hira Mian, Roman Hajek, Efstathios Kastritis, Susan Bal, Joaquin Martinez-Lopez, Andrew Cowan, Chandramouli Nagarajan, Wee-Joo Chng, Allison Tso, Hermann Einsele, Amrita Krishnan, Rakesh Popat, Yi Lin, Darren Pan
Journal: Blood
Blood (2025) 146 (Supplement 1): 4598.
https://doi.org/10.1182/blood-2025-4598
Published: 2025
Journal Articles

Impact of low disease burden on the safety and efficacy of BCMA CAR-T in patients with Relapsed/Refractory multiple myeloma

Free
Kevin Reyes, Tanya Jindal, Sireesha Asoori, Chiung-Yu Huang, Darren Pan, Anupama Kumar, Shagun Arora, Alfred Chung, Peter Sayre, Jeffrey Lee Wolf, Ajai Chari, Thomas Martin, Jodi Lipof
Journal: Blood
Blood (2025) 146 (Supplement 1): 2202.
https://doi.org/10.1182/blood-2025-2202
Published: 2025
Journal Articles

Sequential BCMA- and GPRC5D-targeted bispecific antibody therapy in multiple myeloma: Real-world outcomes and first report of dual bispecific antibody-refractory patients

Free
Darren Pan, Jihong Song, Eva Duvalyn, Samantha Shenoy, Chiung-Yu Huang, Anupama Kumar, Jodi Lipof, Alfred Chung, Jeffrey Lee Wolf, Thomas Martin, Shagun Arora, Peter Sayre, Ajai Chari
Journal: Blood
Blood (2025) 146 (Supplement 1): 5760.
https://doi.org/10.1182/blood-2025-5760
Published: 2025
Journal Articles

Pembrolizumab + GVD with ctdna-guided consolidation for relapsed/refractory classic Hodgkin lymphoma: A multicenter phase 2 Study of the University of California hematologic malignancies consortium

Free
Michael Randall, Wendy Swetzig Dhiman, Chiung-Yu Huang, Charalambos Andreadis, Weiyun Ai, Carrie Ho, Mwanasha Merrill, Madhav Seshadri, Haifaa Abdulhaq, Joseph Tuscano, Nicole Foley, Patricia A. Young, William Pearse, Stephanie Meek, David Kurtz, Michael Spinner
Journal: Blood
Blood (2025) 146 (Supplement 1): 3630.
https://doi.org/10.1182/blood-2025-3630
Published: 2025
Journal Articles

Real world efficacy and safety of elranatamab, a BCMA bispecific antibody for patients with relapsed and refractory multiple myeloma: An international myeloma working group immunotherapy database analysis

Free
Rakesh Popat, Oliver Morjaria, Carlyn Tan, Saad Usmani, Alissa Visram, Susan Bal, Luciano Costa, Roman Hajek, Jana Mihalyova, Joaquin Martinez-Lopez, Adolfo Sáez Marín, Meletios Dimopoulos, Efstathios Kastritis, Chandramouli Nagarajan, Shimin Jasmine Chung, Myo Htut, Wee-Joo Chng, Allison Tso, Thomas Martin, Mrugakshi Dave, Chiung-Yu Huang, Andrew Cowan, Hermann Einsele, Yi Lin, Hira Mian
Journal: Blood
Blood (2025) 146 (Supplement 1): 4588.
https://doi.org/10.1182/blood-2025-4588
Published: 2025
Journal Articles

Combination of Glofitamab with Pirtobrutinib in BTK Inhibitor (BTKi)-Naive or Btki-Intolerant Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium

Free
Madhav R Seshadri, Chiung-Yu Huang, Hildy Donner, William B. Pearse, Patricia A. Young, Monica Mead, Naseem S. Esteghamat, Christine Thacker, Lauren Nguyen, Weiyun Ai, Michael A Spinner, Lawrence David Kaplan, Charalambos Andreadis
Journal: Blood
Blood (2024) 144 (Supplement 1): 3042.3.
https://doi.org/10.1182/blood-2024-209493
Published: 2024
Journal Articles

Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy

Free
Kevin R Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Nina Shah, Sandy W. Wong, Jeffrey L. Wolf, Shagun Arora, Alfred Chung
Journal: Blood
Blood (2022) 140 (Supplement 1): 617–619.
https://doi.org/10.1182/blood-2022-160401
Published: 2022
Journal Articles

Intensity of Cyclophosphamide-Based Bridging Regimens before BCMA-Directed CAR-T Therapy

Free
Aneeqa A Zafar, Chiung-Yu Huang, Mimi Lo, Jen Knoche, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 5218–5220.
https://doi.org/10.1182/blood-2022-162122
Published: 2022
Journal Articles

Outcomes in Patients with Renal Monoclonal Immunoglobulin Deposition Disease

Free
Natasha S Bahri, Alfred Chung, Chiung-Yu Huang, Shagun Arora, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Moming Li, Sandy W. Wong
Journal: Blood
Blood (2022) 140 (Supplement 1): 4285–4286.
https://doi.org/10.1182/blood-2022-167281
Published: 2022
Journal Articles

Trial in Progress: Acalabrutinib Maintenance Following Cellular Therapy for Large B-Cell Lymphoma Patients at High Risk for Relapse

Free
Daria Gaut, Caspian Oliai, Steven Tsai, Chiung-Yu Huang, Joseph Tuscano, Herbert Eradat, Gary J. Schiller
Journal: Blood
Blood (2022) 140 (Supplement 1): 12735–12736.
https://doi.org/10.1182/blood-2022-157466
Published: 2022
Journal Articles

Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma

Free
Kevin R. Reyes, Chiung-Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey L. Wolf, Thomas Martin, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 5105–5107.
https://doi.org/10.1182/blood-2022-160362
Published: 2022
Journal Articles

Phase II Study of Pembrolizumab in Multiple Myeloma Patients Relapsing after or Refractory to Anti-BCMA CAR-T Therapies

Free
Alfred Chung, Chiung-Yu Huang, Thomas Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12651–12652.
https://doi.org/10.1182/blood-2022-170744
Published: 2022
Journal Articles

Significance of the Pee-Value: Relevance of Urine Studies for Patients with Myeloma Undergoing Transplantation

Free
Kelsey H. Natsuhara, Chiung-Yu Huang, Jennifer Knoche, Shagun Arora, Alfred Chung, Thomas Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah, Rahul Banerjee
Journal: Blood
Blood (2022) 140 (Supplement 1): 7910–7912.
https://doi.org/10.1182/blood-2022-155906
Published: 2022
Journal Articles

Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma

Free
Eva Duvalyan, Mimi Lo, Thomas Martin, Jeffrey L. Wolf, Alfred Chung, Shagun Arora, Nina Shah, Chiung-Yu Huang, Sandy W. Wong
Journal: Blood
Blood (2021) 138 (Supplement 1): 1759.
https://doi.org/10.1182/blood-2021-146678
Published: 2021
Journal Articles

Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy

Free
Swetha Kambhampati, MD, Bita Fakhri, MDMPH, Ying Sheng, Chiung-Yu Huang, PhD, Sophia Byslma, BS, Kelsey Natsuhara, MD, Dhruba Biswas, Mimi Lo, PharmD, BCPS, BCOP, Weiyun Z. Ai, Lawrence D Kaplan, MD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Nina Shah, MD, Charalambos Andreadis, MD MSCE, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138940
Published: 2020
Journal Articles

Patterns of Tocilizumab Use Among Myeloma Patients Receiving Bcma-Directed Therapies: Effect on Day 30 Outcomes

Free
Jeffrey Marsal, BS, Rahul Banerjee, MD, Chiung-Yu Huang, PhD, Mimi Lo, PharmD, BCPS, BCOP, Vanessa E Kennedy, MD, Shagun Arora, MD, Jeffrey L. Wolf, MD, Thomas Martin, III, MD, Sandy W. Wong, MD, Nina Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-138618
Published: 2020
Journal Articles

Macrophage Activation Syndrome-like Manifestations (MAS-L) Following BCMA-Directed CAR T-Cells in Multiple Myeloma

Free
Vanessa E Kennedy, MD, Christopher Wong, Chiung-Yu Huang, PhD, Jeffrey L. Wolf, MD, Thomas Martin, MD, Nina Shah, MD, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 7–8.
https://doi.org/10.1182/blood-2020-142612
Published: 2020
Journal Articles

Outcomes of Plasma Cell Leukemia Patients in the Era of Next-Generation Novel Agents: A Single-Center Retrospective Cohort Study

Free
Alex Ge, Chiung-Yu Huang, PhD, Thomas Martin, III, MD, Jeffrey L. Wolf, MD, Nina Shah, MD, Sandy W. Wong, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141525
Published: 2020
Journal Articles

A Five Fold Decrease in Admissions for Uncomplicated Vaso-Occlusive Crisis and Other Benefits from Care in Infusion Clinics: Results from the Escaped Trial

Free
Sophie Lanzkron, MD, Jane Little, MD, Joshua J. Field, MD, Carlton Haywood, Jr., PhDMA, Ravi Varadhan, PhD, Mustapha Saheed, MD, Marc Proudford, Derek Robertson, MBA, JD, Adrienne Kincaid, Lorri Burgess, BS, Charles Green, Hang Wang, PhD, Rebecca Seufert, BS, Jasmine Brooks, BA, Allie Piehet, BS, Brandi Griffin, BSN, RN, Nicole Arnold, Steven Frymark, Chiung- Yu Huang, PhD, Marcus Wallace, MD, Nebras Abu Al Hamayel, MBBS, MPH, Jodi Segal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 853.
https://doi.org/10.1182/blood-2018-99-111484
Published: 2018
Journal Articles

Patient Satisfaction of Care in the Treatment of Vaso-Occlusive Crises: A Comparison of Emergency Department and Infusion Centers in the Escaped Study

Free
Nebras Abu Al Hamayel, MBBS, MPH, Jasmine Brooks, BA, Hang Wang, PhD, Rebecca Seufert, BS, Carlton Haywood, Jr., PhDMA, Ravi Varadhan, PhD, Mustapha Saheed, MD, Jodi Segal, MD, Chiung-Yu Huang, PhD, Joshua J. Field, MD, Steven Frymark, Jane Little, MD, Brandi Griffin, BSN, RN, Nicole Arnold, Joseph Ryan Shows, MD, Allie Piehet, BS, Marc Proudford, Derek Robertson, MBA, JD, Marcus Wallace, MD, Adrienne Kincaid, Charles Green, Lorri Burgess, BS, Sophie Lanzkron, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 314.
https://doi.org/10.1182/blood-2018-99-111544
Published: 2018